Skip to main content

Table 1 Clinical characteristics of SMA patients

From: 1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy

ID

Age

Gender

SMA type

SMN1 mutation

SMN2 copies

Ambula-tory

CHOP-INTEND (max. 64)

HFSME (max. 66)

RULM (max. 37)

SMA001

2 m

M

PRE

Hom. Δ7/8

4

No

59

 

SMA002

4 m

M

PRE

Hom. Δ7/8

4

No

54

SMA003

7 m

F

PRE

Hom. Δ7/8

5

No

64

SMA004

1y 2 m

F

PRE

Hom. Δ7/8

5

No

SMA005

3 m

F

PRE

Hom. Δ7, Het. Δ8

4

No

62

SMA006

2 m

F

1

Hom. Δ7/8

2

No

22

SMA007

4 m

F

1

Hom. Δ7/8

2

No

22

SMA008

3 m

M

1

Hom. Δ7/8

2

No

13

SMA009

5 m

M

1

Het. Δ7/8, (c.46delG)

2

No

20

SMA010

5 m

M

1

Hom. Δ7

2

No

28

SMA011

9 m

M

1

Hom. Δ7/8

3

No

32

SMA012

14y

F

1

Hom. Δ7/8

2

No

18

1

SMA013

16y 10 m

F

1

Hom. Δ7/8

3

No

10

5

SMA014

5y 5 m

F

1

Hom. Δ7

3

No

SMA015

1y 2 m

F

2

Hom. Δ7

3

No

10

SMA016

1y 5 m

M

2

Hom. Δ7/8

3

No

44

SMA017

2y 6 m

F

2

Hom. Δ7/8

3

No

59

12

SMA018

9y

M

2

Hom. Δ7/8

3

No

26

6

SMA019

14y 8 m

M

2

Hom. Δ7

3

No

7

21

SMA020

17y 8 m

F

2

Hom. Δ7/8

3

No

17

25

SMA021

18y

M

2

Hom. Δ7/8

3

No

0

6

SMA022

18y 11 m

F

2

Hom. Δ7/8

3

No

2

15

SMA023

3y 2 m

F

3a

Hom. Δ7/8

3

Yes

36

11

SMA024

8y 3 m

F

3a

Hom. Δ7/8

3

No

SMA025

8y 9 m

F

3a

Hom. Δ7/8

3

No

22

21

SMA026

12y 8 m

F

3a

Hom. Δ7/8

3

No

31

23

SMA027

3y 5 m

M

3b

Hom. Δ7, Het. Δ8

2

Yes

50

20

SMA028

4y 4 m

M

3b

Hom. Δ7/8

4

Yes

44

21

SMA029

14y 1 m

F

3b

Hom. Δ7/8

4

Yes

54

33

  1. CHOP-INTEND, Children’s Hospital of Philadelphia Infant Test of Neuromuscular Disorders; Δ/del, deletion; F, female; het, heterozygous; HFSME, Hammersmith Functional Motor Scale Expanded; hom, homozygous; M, male; m, months; PRE, pre-symptomatic; RULM, Revised Upper Limb Module; SMA, spinal muscular atrophy; y, years